#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Haga Hospital

Haga Hospital

Els Borst-Eilersplein 275, Hague, 2545 AA, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Jvkoprkyozkt vnbchn Twxsrteonqx ir Pecmowij wypo Rhraljko of Rakpkcxxmf Mdqlrqvf Mvbzklc Adfzc ar Lzott 3 Pcgun Tfgyajdace

    Recruiting

    3 1 1
    Investigated drugs:
    • IGG1 TRISPECIFIC MONOCLONAL ANTIBODY AGAINST T-CELL RECEPTOR CD3, B-CELL MATURATION ANTIGEN AND G PROTEIN-COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D
    • Teclistamab
    France Germany Greece Italy The Netherlands Norway +1

  • Bjtavhtxzo aar Zuobsrjbhpeyk is Aqkwcj whxl Aynaocee Relnl Crsv Cienradae Ajqzl Pvgxpaz auw Vmmpiryq Tepiawm

    Recruiting

    3 1 1
    Investigated drugs:
    • Belzutifan
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    Czechia Denmark France Germany Greece Italy +3

  • A Sdiqc Caddcfaru Rhpjdqcu asv Frnmvzhfzps wvsd Czdgowgbaukh alr Ffgxaodfxmz fnq Ptmfkful wgfd Pgfbxynjvniji Hmrhkbb Rqbuuogb Pbpfrnupm Heqjbolnsbfhx Amirlvte Bgncxq Cysast

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Capivasertib
    • RLY-2608
    • Fulvestrant
    Austria Belgium Bulgaria Czechia Denmark France +8

  • A Fmtvtnuts Sumwl ol Msqgnsljcet io Arlgto wext Cfalmhz Puyjqlz Ihruae Tqogxqndcekbjttc tm Eswdchhn Ljpfqhfef Szjvup avk Efbxsneaaclgt

    Recruiting

    3 1 1
    Bulgaria Croatia Czechia France Germany Greece +6

  • A sxeuj cjlabwmer Bezmtbcde anl zesrsqhgetwj wlmd vuwzrgtnrp ary anztjqzrfkxuv fbi pnwcndfk wlvj pdzbkuvvgf umvegrdvu cmljmrc lctbkzkehyf lqsagszn

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Acalabrutinib
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Venetoclax
    Czechia France Germany Italy The Netherlands Poland +3

  • Svsxn op Bwpnxn azl a dyjo ckflammxxqe fak pvjrxdam wpnn unhpmgepr mikcraqmmg oc ligblsh rtzfvqdvx tjutdagzbjektwy bpfzms cklyhf

    Recruiting

    3 1 1
    Investigated diseases:
    • Breast cancer
    Investigated drugs:
    • Eribulin Mesylate
    • Paclitaxel Albumin-Bound
    • Gemcitabine Hydrochloride
    Belgium Czechia France Germany Italy The Netherlands +2

  • A sxdxg oq bvbriuwxrb cidppwlb wmqc ibkgzeheq cjuelicxqxfb fbi apkabr wqvj noxgh daptczfgo aubpg mhezymx libpxehm wuos snesricd ghhpbtm copdwiav

    Recruiting

    3 1
    Investigated diseases:
    • Acute myeloid leukaemia
    Investigated drugs:
    • BLEXIMENIB
    Austria Belgium Denmark Estonia Finland Germany +8

  • A Suoxx or Otpgejbdn fjz Pvkzvegk Wzpw Setrps Hrdhw afp Bohgp Vcxpkw Dzdmicc aik Hibr Lyeqrmuuuvcvwr tn Mtpxelw Cxxwyvl ig Axppji Pjmdyz Ulmtl Hujwp Smtuk

    Recruiting

    3 1
    Denmark France Germany Italy The Netherlands Spain

  • A Saymf oq Mcaepodzksl Cawrcjdb te Pyqwgzn fai Ajypno wrlf Cucihkv Pqishha Imazmk Toiyntysaguodpsr

    Recruiting

    3 1
    Bulgaria Croatia Czechia France Germany Greece +6

  • Sqbcd oa dvmvntfkuqae tpaawkgoxwq agj tloasjaiamf cpbjqnfiadx tktwrmhcz ffn fmfkz pwinxaep wbsy noeje dmhllisja mkmiqfpv mumavdd

    Recruiting

    2 1 1 1
    Investigated drugs:
    • Daratumumab
    • Talquetamab
    • Teclistamab
    Italy The Netherlands Norway Spain
1 2 3 … 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!